Scarica l'app Stockscreener
6.01
1.15%
-0.07
Upstream Bio Inc Borsa (UPB) Ultime notizie
Why Did UPB Stock Plunge 40% Today? - Stocktwits
Norges Bank Initiates New Position in Upstream Bio Inc (UPB) with 4.2 Million Share Purchase - GuruFocus
Upstream Bio, Inc. (NASDAQ: UPB) Share Price, UPB Stock News, UPB Share Price & Updates - Kalkine
Walleye Capital LLC Invests $3.45 Million in Upstream Bio, Inc. $UPB - MarketBeat
Upstream Bio (NASDAQ:UPB) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Upstream Bio (NASDAQ:UPB) Given New $9.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Q3 EPS Estimates for Upstream Bio Decreased by HC Wainwright - MarketBeat
Marie Sanchirico takes charge of Medical Affairs at Upstream Bio, Inc. to drive physician engagement - Traders Union
Truist Financial Maintains UpStream Bio(UPB.US) With Buy Rating, Maintains Target Price $25 - Moomoo
H.C. Wainwright Maintains UpStream Bio(UPB.US) With Buy Rating, Maintains Target Price $36 - Moomoo
Upstream Bio (UPB) Slides 2.54% as Biotech Caution Persists: Key Levels to WatchInstitutional Buy Signals - Vinanet
A Quick Look at Today's Ratings for UpStream Bio(UPB.US), With a Forecast Between $19 to $36 - Moomoo
Truist Financial Maintains UpStream Bio(UPB.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Upstream Bio Targets Q1 2027 Start for Phase - Minichart
Upstream Bio (NASDAQ:UPB) Announces Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
UPB: Verekitug demonstrated robust efficacy and safety, advancing to Phase 3 for severe asthma and CRSWNP - TradingView
Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNP - Bitget
Pstream Bio stock rises 2.6% after Q2 results and pipeline update - Traders Union
Form 8K Upstream Bio Inc For: 11 August By Investing.com - Investing.com Canada
Upstream Bio, Inc. 2Q 2026: Revenue $0.8M, EPS $(0.73) — 10-Q Summary - TradingView
Upstream Bio (UPB) deepens R&D spend but ends quarter with $261M cash - Stock Titan
Upstream Bio Q2 net loss narrows slightly on lower R&D costs - TradingView
Upstream Bio reports Q2 2026 net loss $39.7M, cash and short-term investments $261.3M - TradingView
Upstream Bio Posts $39.7 Million Q2 Net Loss as Trials Advance - Quiver Quantitative
Upstream Bio, Inc. sets Phase 3 trial for sever asthma and CRSwNP in Q1 2027 - Traders Union
Upstream Bio (NASDAQ: UPB) reports Q2 2026 loss and advances Phase 3 plans - Stock Titan
Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress - Caledonian Record
Upstream Bio (UPB) Rises 0.94% to $7.51 as Biotech Stock Holds Key SupportAdvance Decline Volume - dars.gov.et
Upstream Bio Inc (UPB) Stock News Today - TradingKey
Upstream Bio Inc (UPB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Upstream Bio, Inc. (UPB) Stock Analysis: A Hidden Gem in Biotechnology with a 456% Potential Upside - DirectorsTalk Interviews
Arrowstreet Capital Limited Partnership Buys New Holdings in Upstream Bio, Inc. $UPB - MarketBeat
BlackRock, Inc. Trims Stake in Upstream Bio Inc (UPB) Amid Clini - GuruFocus
Upstream Bio, Inc. (NASDAQ:UPB) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Upstream Bio (UPB) Gains Ground: Testing Key Resistance Levels After 2.5% AdvanceBox Spread - dars.gov.et
Upstream Bio (UPB) Expected to Release Quarterly Earnings on Wednesday - MarketBeat
Upstream Bio Inc (UPB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Upstream Bio Inc (UPB) Cash Flow - TradingKey
UPB|Upstream Bio Inc|Price:6.780|Chg%:+0.360 - TradingKey
UPB|Upstream Bio Inc|Price:6.400|Chg%:-0.010 - TradingKey
Upstream Bio Inc (UPB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Upstream Bio Inc (UPB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Upstream Bio Inc (UPB) Balance Sheet - TradingKey
Upstream Bio Inc (UPB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
UPB|Upstream Bio Inc|Price:7.450|Chg%:+0.200 - TradingKey
Upstream Bio Inc. (UPB) Holds Steady Near Support as Traders Eye Resistance BreakoutHigh Yield Stocks - dars.gov.et
Upstream Bio Inc (UPB) Income Statement - TradingKey
Upstream Bio, Inc. Revenue Breakdown – NASDAQ:UPB - TradingView
Upstream Bio (UPB) Holds Steady Near Support as Traders Eye Key Resistance LevelsRip Sell Trade - vinanet.vn
Decheng Capital LLC Sells 418,210 Shares of Upstream Bio, Inc. $UPB - MarketBeat
SEB Asset Management AB Buys New Stake in Upstream Bio, Inc. $UPB - MarketBeat
Enterprise value to revenue forward of Upstream Bio, Inc. – NASDAQ:UPB - TradingView
ETFs Investing in Upstream Bio, Inc. Stocks - TradingView
Upstream Bio (UPB) Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline AdvancesEPS Estimate Trend - vinanet.vn
Upstream Bio, Inc. (UPB) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
UPB Q1 2026 Earnings: Narrower Loss Beats Estimates Amid Clinical ProgressEarnings Season Preview - DonanımHaber
Upstream Bio Inc. (UPB) Q1 2026 Earnings: EPS Beat Expectations Amid Clinical Pipeline ProgressProfit Margin Analysis - dars.gov.et
Upstream Bio Q1 2026 Earnings: Narrower Loss Beats Expectations, Stock Declines in Pre-Revenue PhaseReturn On Capital - dars.gov.et
Price to earnings forward of Upstream Bio, Inc. – NASDAQ:UPB - TradingView
Price to book forward of Upstream Bio, Inc. – NASDAQ:UPB - TradingView
Upstream Bio Inc. Q1 2026 Earnings: Narrower Loss Beats Expectations as Pipeline AdvancesFree Cash Flow Trends - dars.gov.et
UPBUpstream Bio Inc Dividends - Finviz
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):